文献速递胰腺与胆道疾病消化内镜

局部术后冷冻预防显著降低ERCP术后胰腺炎发生率:一项多中心随机对照试验

Local Postprocedural Cryoprevention Significantly Reduces the Incidence of Post-ERCP Pancreatitis: A Multicenter Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2025-07-10

这项在日本8家医院开展的单盲多中心随机对照试验纳入880例原生乳头接受ERCP的成人,分析877例(冷冻预防组434例、对照组443例)。冷冻预防组PEP发生率为3.2%,显著低于对照组的6.8%(P=0.02),绝对风险降低3.6%、相对风险降低52.4%,未报告与冷冻预防相关的不良事件。

要点

  • 冷冻预防组PEP发生率3.2%,显著低于对照组6.8%(P=0.02)。
  • 绝对风险降低3.6%,相对风险降低52.4%。
  • 胆管炎、出血、穿孔等次要结局两组无显著差异,未报告冷冻预防相关不良事件。

核心结论

  • 使用冰水对乳头进行冷冻预防可显著降低PEP发生率,是一种安全、有效且低成本的策略。
  • 该方法为NSAIDs使用受限的情况提供了实用的替代选择。

研究设计与样本

  • 多中心、单盲、随机对照试验,在日本8家医院开展,时间为2022年3月至2024年2月。
  • 纳入880例原生乳头接受ERCP的成人,排除3例退出后分析877例(冷冻预防组434例、对照组443例)。
  • 主要结局为PEP发生率,定义为术后24小时内腹痛且血清淀粉酶或脂肪酶≥正常上限3倍。
  • 次要结局包括胆管炎、出血、穿孔和死亡。

主要发现

  • 冷冻预防组PEP发生率为3.2%(95%CI 1.7%-5.4%),对照组为6.8%(95%CI 4.6%-9.6%),P=0.02。
  • 绝对风险降低3.6%,相对风险降低52.4%。
  • 胆管炎发生率冷冻预防组0.9% vs 对照组1.1%(P=1.00),出血1.4% vs 2.5%(P=0.33),穿孔0.9% vs 0.2%(P=0.21),均无显著差异。
  • 对照组1例患者死于重症PEP,未报告与冷冻预防相关的不良事件。

临床怎么用

  • 作者认为冷冻预防使用冰水可显著降低PEP发生率,是安全、有效且低成本的策略。
  • 作者认为该方法在NSAIDs使用受限的情况下提供了实用的替代选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a common, potentially serious adverse event of ERCP. Although rectal nonsteroidal anti-inflammatory drugs are recommended for prevention, their use in Japan is limited due to dosage concerns. This multicenter randomized controlled trial evaluated the efficacy and safety of ice water irrigation to the papilla in reducing PEP. METHODS: This single-blind trial enrolled 880 adults with a native papilla undergoing ERCP at 8 hospitals in Japan (March 2022-February 2024). After 3 withdrawals, 877 were analyzed (cryoprevention: 434; control: 443). The primary outcome was PEP incidence, defined as abdominal pain within 24 hours and serum amylase or lipase ≥3 times the upper normal limit. Secondary outcomes included cholangitis, bleeding, perforation, and mortality. RESULTS: PEP incidence was significantly lower in the cryoprevention group (3.2%; 95% CI, 1.7%-5.4%) than the control group (6.8%; 95% CI, 4.6%-9.6%) ( P = 0.02), with absolute and relative risk reductions of 3.6% and 52.4%. No significant differences were observed in secondary outcomes, including cholangitis (0.9% vs 1.1%; P = 1.00), bleeding (1.4% vs 2.5%; P = 0.33), or perforation (0.9% vs 0.2%; P = 0.21). One control patient died from severe PEP. No adverse events related to cryoprevention were reported. DISCUSSION: Cryoprevention using ice water significantly reduced PEP incidence, demonstrating a safe, effective, and low-cost strategy. This approach offers a practical alternative, where nonsteroidal anti-inflammatory drugs use is limited.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Azuma S, Kobayashi Y, Harada R, et al. Local Postprocedural Cryoprevention Significantly Reduces the Incidence of Post-ERCP Pancreatitis: A Multicenter Randomized Controlled Trial. Am J Gastroenterol. 2025. PMID: 40638082. doi:10.14309/ajg.0000000000003644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。